Genome variation and personalized cancer medicine.

Genome variation and personalized cancer medicine.

Item
http://www.wikidata.org/entity/Q38113300
Detection of lower levels of SNAP25 using multiple microarray systems and its functional significance in medulloblastomaA 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseasesCommon polymorphism in the MMP-13 gene may contribute to the risk of human cancers: a meta-analysis.Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis.NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.Molecular markers to guide primary radical treatment selection in localized prostate cancer.Medulloblastoma development: tumor biology informs treatment decisionsDetection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancerAutomated quantitative multiplex immunofluorescence in situ imaging identifies phospho-S6 and phospho-PRAS40 as predictive protein biomarkers for prostate cancer lethality.Lessons learned and challenges posed in cancer genetics. Introduction.
P2860

Genome variation and personalized cancer medicine.

Item
http://www.wikidata.org/entity/Q38113300
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Genome variation and personalized cancer medicine.
@en
type
label
Genome variation and personalized cancer medicine.
@en
prefLabel
Genome variation and personalized cancer medicine.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
Genome variation and personalized cancer medicine.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698